Zhou C - Search Results

1

Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2).

Ou SI, Nishio M, Ahn MJ, Mok T, Barlesi F, Zhou C, Felip E, de Marinis F, Kim SW, Pérol M, Liu G, Migliorino MR, Kim DW, Novello S, Bearz A, Garrido P, Mazieres J, Morabito A, Lin HM, Yang H, Niu H, Zhang P, Kim ES. Ou SI, et al. Among authors: zhou c. J Thorac Oncol. 2022 Dec;17(12):1404-1414. doi: 10.1016/j.jtho.2022.08.018. Epub 2022 Sep 10. J Thorac Oncol. 2022. PMID: 36096442 Free article.

2

Efficacy and safety of erlotinib in 1242 East/South-East Asian patients with advanced non-small cell lung cancer.

Mok T, Wu YL, Au JS, Zhou C, Zhang L, Perng RP, Park K. Mok T, et al. Among authors: zhou c. J Thorac Oncol. 2010 Oct;5(10):1609-15. doi: 10.1097/JTO.0b013e3181e15d55. J Thorac Oncol. 2010. PMID: 20808255 Free article. Clinical Trial.

3

Safety and efficacy of first-line bevacizumab with chemotherapy in Asian patients with advanced nonsquamous NSCLC: results from the phase IV MO19390 (SAiL) study.

Tsai CM, Au JS, Chang GC, Cheng AC, Zhou C, Wu YL. Tsai CM, et al. Among authors: zhou c. J Thorac Oncol. 2011 Jun;6(6):1092-7. doi: 10.1097/JTO.0b013e318216687d. J Thorac Oncol. 2011. PMID: 21512405 Free article. Clinical Trial.

4

KIF5B-RET fusions in Chinese patients with non-small cell lung cancer.

Cai W, Su C, Li X, Fan L, Zheng L, Fei K, Zhou C. Cai W, et al. Among authors: zhou c. Cancer. 2013 Apr 15;119(8):1486-94. doi: 10.1002/cncr.27940. Epub 2013 Feb 1. Cancer. 2013. PMID: 23378251 Free article.

5

Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial.

Wu YL, Lee JS, Thongprasert S, Yu CJ, Zhang L, Ladrera G, Srimuninnimit V, Sriuranpong V, Sandoval-Tan J, Zhu Y, Liao M, Zhou C, Pan H, Lee V, Chen YM, Sun Y, Margono B, Fuerte F, Chang GC, Seetalarom K, Wang J, Cheng A, Syahruddin E, Qian X, Ho J, Kurnianda J, Liu HE, Jin K, Truman M, Bara I, Mok T. Wu YL, et al. Among authors: zhou c. Lancet Oncol. 2013 Jul;14(8):777-86. doi: 10.1016/S1470-2045(13)70254-7. Epub 2013 Jun 17. Lancet Oncol. 2013. PMID: 23782814 Clinical Trial.

6

How sensitive are epidermal growth factor receptor-tyrosine kinase inhibitors for squamous cell carcinoma of the lung harboring EGFR gene-sensitive mutations?

Zhou F, Chen X, Zhou C. Zhou F, et al. Among authors: zhou c. J Thorac Oncol. 2014 Feb;9(2):e19-20. doi: 10.1097/JTO.0000000000000046. J Thorac Oncol. 2014. PMID: 24419431 Free article. No abstract available.

7

Atypical negative ALK break-apart FISH harboring a crizotinib-responsive ALK rearrangement in non-small-cell lung cancer.

Ren S, Hirsch FR, Varella-Garcia M, Aisner DL, Boyle T, Zhou C, Camidge DR. Ren S, et al. Among authors: zhou c. J Thorac Oncol. 2014 Mar;9(3):e21-3. doi: 10.1097/JTO.0000000000000013. J Thorac Oncol. 2014. PMID: 24518095 Free PMC article. No abstract available.

8

The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non-small cell lung cancer.

Zhao M, Zhang Y, Cai W, Li J, Zhou F, Cheng N, Ren R, Zhao C, Li X, Ren S, Zhou C, Hirsch FR. Zhao M, et al. Among authors: zhou f, zhou c. Cancer. 2014 Aug 1;120(15):2299-307. doi: 10.1002/cncr.28725. Epub 2014 Apr 15. Cancer. 2014. PMID: 24737648 Free article.

9

Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFR.

Ren S, Su C, Wang Z, Li J, Fan L, Li B, Li X, Zhao C, Wu C, Hou L, He Y, Gao G, Chen X, Ren J, Li A, Xu G, Zhou X, Zhou C, Schmid-Bindert G. Ren S, et al. Among authors: zhou x, zhou c. Int J Cancer. 2014 Dec 15;135(12):2962-71. doi: 10.1002/ijc.28925. Epub 2014 May 7. Int J Cancer. 2014. PMID: 24771540

10

Dynamic volume perfusion computed tomography parameters versus RECIST for the prediction of outcome in lung cancer patients treated with conventional chemotherapy.

Sudarski S, Shi J, Schmid-Bindert G, Manegold C, Pilz LR, Zhou C, Schoenberg SO, Henzler T. Sudarski S, et al. Among authors: zhou c. J Thorac Oncol. 2015 Jan;10(1):164-71. doi: 10.1097/JTO.0000000000000376. J Thorac Oncol. 2015. PMID: 25247342 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,487 results

Search Page